Time Series Modeling and Forecasting of Drug-Related Deaths in Iran (2014-2016).

Drug abuse Forecasting Poisoning Time series Trend

Journal

Addiction & health
ISSN: 2008-4633
Titre abrégé: Addict Health
Pays: Iran
ID NLM: 101582275

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 20 06 2021
accepted: 08 09 2021
medline: 29 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: ppublish

Résumé

Investigating the temporal variations and forecasting the trends in drug-related deaths can help prevent health problems and develop intervention programs. The recent policy in Iran is strongly focused on deterring drug use and replacing illicit drugs with legal ones. This study aimed to investigate drug-related deaths in Iran in 2014-2016 and forecast the death toll by 2019. In this longitudinal study, Box-Jenkins time series analysis was used to forecast drug-related deaths. To this end, monthly counts of drug-related deaths were obtained from March 2014 to March 2017. After data processing, to obtain stationary time series and examine the stability assumption with the Dickey-Fuller test, the parameters of the Autoregressive Integrated Moving Averages (ARIMA) model were determined using autocorrelation function (ACF) and partial autocorrelation function (PACF) graphs. Based on Akaike statistics, ARIMA (0, 1, 1) was selected as the best-fit model. Moreover, the Dickey-Fuller test was used to confirm the stationarity of the time series of transformed observations. The forecasts were made for the next 36 months using the ARIMA (0,1,2) model and the same confidence intervals were applied to all months. The final extracted data were analyzed using R software, Minitab, and SPSS-23. According to the Iranian Ministry of Health and the Legal Medicine Organization, there were 8883 drug-related deaths in Iran from March 2014 to March 2017. According to the time series findings, this count had an upward trend and did not show any seasonal pattern. It was forecasted that the mean drug-related mortality rate in Iran would be 245.8 cases per month until 2019. This study showed a rising trend in drug-related mortality rates during the study period, and the modeling process for forecasting suggested this trend would continue until 2019 if proper interventions were not instituted.

Sections du résumé

Background UNASSIGNED
Investigating the temporal variations and forecasting the trends in drug-related deaths can help prevent health problems and develop intervention programs. The recent policy in Iran is strongly focused on deterring drug use and replacing illicit drugs with legal ones. This study aimed to investigate drug-related deaths in Iran in 2014-2016 and forecast the death toll by 2019.
Methods UNASSIGNED
In this longitudinal study, Box-Jenkins time series analysis was used to forecast drug-related deaths. To this end, monthly counts of drug-related deaths were obtained from March 2014 to March 2017. After data processing, to obtain stationary time series and examine the stability assumption with the Dickey-Fuller test, the parameters of the Autoregressive Integrated Moving Averages (ARIMA) model were determined using autocorrelation function (ACF) and partial autocorrelation function (PACF) graphs. Based on Akaike statistics, ARIMA (0, 1, 1) was selected as the best-fit model. Moreover, the Dickey-Fuller test was used to confirm the stationarity of the time series of transformed observations. The forecasts were made for the next 36 months using the ARIMA (0,1,2) model and the same confidence intervals were applied to all months. The final extracted data were analyzed using R software, Minitab, and SPSS-23.
Findings UNASSIGNED
According to the Iranian Ministry of Health and the Legal Medicine Organization, there were 8883 drug-related deaths in Iran from March 2014 to March 2017. According to the time series findings, this count had an upward trend and did not show any seasonal pattern. It was forecasted that the mean drug-related mortality rate in Iran would be 245.8 cases per month until 2019.
Conclusion UNASSIGNED
This study showed a rising trend in drug-related mortality rates during the study period, and the modeling process for forecasting suggested this trend would continue until 2019 if proper interventions were not instituted.

Identifiants

pubmed: 38026723
doi: 10.34172/ahj.2023.1277
pmc: PMC10658097
doi:

Types de publication

Journal Article

Langues

eng

Pagination

149-155

Informations de copyright

© 2023 Kerman University of Medical Sciences.

Déclaration de conflit d'intérêts

Competing Interests The authors declare that they have no conflict of interest.

Références

Am J Forensic Med Pathol. 2019 Jun;40(2):99-101
pubmed: 30789365
Third World Q. 2018;39(2):277-297
pubmed: 29456274
Addict Health. 2020 Apr;12(2):87-97
pubmed: 32782731
Arch Iran Med. 2014 May;17(5):321-35
pubmed: 24784861
Iran J Public Health. 2019 Jan;48(1):187-188
pubmed: 30847332
Spat Spatiotemporal Epidemiol. 2018 Jun;25:19-24
pubmed: 29751889
Basic Clin Pharmacol Toxicol. 2018 Apr;122(4):436-441
pubmed: 29076627
Addiction. 2016 Oct;111(10):1836-47
pubmed: 27177849
Arch Iran Med. 2015 Aug;18(8):480-5
pubmed: 26265515
Scand J Public Health. 2019 Jun;47(4):452-461
pubmed: 29886813
Int J Drug Policy. 2019 Jan;63:90-96
pubmed: 30513474
JAMA. 2018 May 1;319(17):1819-1821
pubmed: 29715347
Curr Opin Psychiatry. 2018 Jul;31(4):300-305
pubmed: 29746420
Int J High Risk Behav Addict. 2015 Dec 01;4(4):e22863
pubmed: 26870709
J Health Commun. 2013 Aug;18(8):898-912
pubmed: 23742712
Lancet Public Health. 2019 Feb;4(2):e97-e106
pubmed: 30655229
Riv Psichiatr. 2018 Sep-Oct;53(5):233-255
pubmed: 30353199
Addiction. 2018 Mar;113(3):464-472
pubmed: 28841781
Addict Health. 2018 Oct;10(4):260-268
pubmed: 31263525

Auteurs

Mehran Zarghami (M)

Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Department of Psychiatry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Omid Kharazmi (O)

Department of Statistics, Faculty of Mathematical Sciences, Vali-e-Asr University of Rafsanjan, Rafsanjan, Iran.

Abbas Alipour (A)

Community Medicine Department, Medical Faculty, Mazandaran University of Medical Sciences, Sari, Iran.

Masoudeh Babakhanian (M)

Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran.
Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Ardeshr Khosravi (A)

Deputy for Public Health, Ministry of Health and Medical Education, Tehran, Iran.

Seyyed Davood Mirtorabi (SD)

Legal Medicine Research Center, Legal Medicine Organization, Tehran, Iran.

Classifications MeSH